ImmuCell Reports More Advance Q4 Sales (NASDAQ: ICCC)


  • ImmuCell Corporation (NASDAQ:ICCC) announced preliminary sales of $7.8 million in the fourth quarter, up 52% ​​from the fourth quarter of 2023.
  • Co sees fiscal 2024 sales of $26.5 million, also up 52% ​​from 2023.
  • The company believes the current backlog reflects strong demand as distributors work to replenish their buffer stocks and as end users place orders ahead of the peak calving season in the first quarter.
  • Source: Press release



Source link

  • Related Posts

    Whitehall is preparing for spending cuts after the UK was hit by the bond market turmoil

    Unlock Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favorite stories in this weekly newsletter. Whitehall departments are bracing for tougher spending settlements this summer as…

    Access to this page has been denied.

    Access to this page has been denied because we believe you are using automation tools to navigate the website. This can happen as a result of the following: Javascript is…

    Leave a Reply

    Your email address will not be published. Required fields are marked *